Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
Authors
Keywords
Immunotherapy, Phase 1 clinical trials, Sites of metastasis, Liver metastasis, Clinical outcomes, Tumor immunology, Tumor microenvironment, Immune checkpoint blockade
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-29
DOI
10.1186/s12885-019-6073-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events
- (2018) Dylan J. Martini et al. Cancer Immunology Research
- Immune checkpoint blockade for advanced non-small cell lung cancer: challenging clinical scenarios
- (2018) Rebecca Tay et al. Journal of Thoracic Disease
- Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Journal for ImmunoTherapy of Cancer
- Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer
- (2018) Tamkin Ahmadzada et al. Journal of Clinical Medicine
- Distinct patterns of response and toxicity (tox) by sites of metastases (mets) in patients (pts) treated with ipilimumab combined with PD-1 antibodies (ipi+PD1).
- (2018) Ines Esteves Domingues Pires Da Silva et al. JOURNAL OF CLINICAL ONCOLOGY
- Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy
- (2017) David D. Chism Journal of the National Comprehensive Cancer Network
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Targeting the programmed cell death-1 pathway in breast and ovarian cancer
- (2016) Leisha A. Emens et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- A meta-analysis of efficacy and safety of antibodies targeting PD-1/PD-L1 in treatment of advanced nonsmall cell lung cancer
- (2016) Cuihua Wang et al. MEDICINE
- Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy
- (2016) Xinqi Wu et al. Cancer Immunology Research
- Breast Cancer Subtypes Predispose the Site of Distant Metastases
- (2015) Abha Soni et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant
- (2015) Kobe Reynders et al. CANCER TREATMENT REVIEWS
- Mechanisms involved in breast cancer liver metastasis
- (2015) Rui Ma et al. Journal of Translational Medicine
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prognostic significance of PD-L1 in bladder cancer
- (2015) YIDE HUANG et al. ONCOLOGY REPORTS
- Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
- (2015) Ninh M. La-Beck et al. PHARMACOTHERAPY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma
- (2014) David McDermott et al. CANCER TREATMENT REVIEWS
- Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
- (2014) Rituparna Das et al. JOURNAL OF IMMUNOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Liver-primed CD8+T cells suppress antiviral adaptive immunity through galectin-9-independent T-Cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice
- (2013) Joseph S. Dolina et al. HEPATOLOGY
- Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients WithKRASWild-Type Unresectable Colorectal Liver-Limited Metastases
- (2013) Le-Chi Ye et al. JOURNAL OF CLINICAL ONCOLOGY
- Resection of liver metastases in patients with breast cancer: Survival and prognostic factors
- (2012) G.A.M. van Walsum et al. EJSO
- The liver, liver metastasis and liver cancer: a special case for immunotherapy with cytokines and immunostimulatory monoclonal antibodies
- (2012) Guillermo Mazzolini et al. Immunotherapy
- Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center
- (2011) Ignacio Garrido-Laguna et al. CANCER
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
- (2010) Chuan-Yong Mu et al. MEDICAL ONCOLOGY
- Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials
- (2009) Hendrik-Tobias Arkenau et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
- (2008) H-T Arkenau et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search